The chronic anaemia of rheumatoid arthritis: Iron banking or blocking?

Lancet

Volumn 360, Issue 9347, 2002, Pages 1713-1714

  Fitzsimons, Edward J ^a   Sturrock, Roger D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; APOPTOSIS; BLOOD TRANSFUSION; DISEASE ACTIVITY; DISEASE COURSE; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; HEMOGLOBIN DETERMINATION; HUMAN; NOTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0037202848     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11725-9     Document Type: Note

References (10)

1. Health Service Circular. Better Blood Transfusion: Appropriate use of Blood. HSC2002/009. London:Department of Health, 2002. http://www.doh.gov.uk/bbt2%5C009hsc2002.pdf (accessed Nov 19, 2002).
2. Konijn A.M., Hershko C. Ferritin synthesis in inflammation: pathogenesis of impaired iron release. Br J Haematol. 37:1977;7-16.
3. Papadaki H.A., Kritikos H.D., Gemetzi C., et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood. 99:2002;1610-1619.
4. Papadaki H.A., Kritikos H.D., Valatas V., Boumpas D.T., Eliopoulos G.D. Anemia of chronic disease in rheumatoid arthritia is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-α antibody therapy. Blood. 100:2002;474-482.
5. Davis D., Charles P.J., Potter A., Feldmann M., Maini R.N., Elliot M.J. Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor α blockade. Br J Rheumatol. 36:1997;950-956.
6. Drosos A.A., Psychos D., Andonopoulos A.P., Stefanaki-Nikou S., Tsianos E.B., Moutsopoulos H.M. Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up. Clin Rheumatol. 9:1990;333-341.
7. Fitzsimons E.J., Houston T., Munro R., Sturrock R.D., Speekenbrink A.B.J., Brock J.H. Erythroblast iron metabolism and serum soluble transferring receptor values in the anaemia of rheumatoid arthritis. Arthritis Rheum. 47:2002;166-171.
8. Shominen P., Mottoneu T., Rajimaki A., Kertuu I. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect time and functional iron deficiency in rheumatoid arthritis patients with anaemia. Arthritis Rheum. 43:2000;1016-1020.
9. Klausner R.D., Rouault T.A., Harford J.T. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell. 72:1993;19-28.
10. Leandro M.J., Edwards J.C., Cambridge G. Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis. 61:2002;883-888.